• ESTIMATION OF TRANSITION PROBABILITIES BETWEEN CERVICAL LESIONS FOR THE NATURAL HISTORY OF CERVICAL CANCER AMONG CHINESE WOMEN

    May 1, 2016, 00:00

  • Levodopa/Carbidopa Intestinal Gel Treatment and Its Impact on Quality of Life and Work Ability in Patients with Parkinson’s Disease in Czech Republic

    May 1, 2016, 00:00

  • BUDGET IMPACT MODEL FOR SELEXIPAG- TAKING A US PAYER PERSPECTIVE

    May 1, 2016, 00:00

  • Knowledge, Attitudes, And Practice Towards Use of Long-Term Family Planning Methods Among Women Aged 15-49 Years- A Community-Based Survey in an Urban Ugandan Setting

    May 1, 2016, 00:00

  • Six-Month Cost Assessment After Copd-Related Hospital Or Emergency Department Visits

    May 1, 2016, 00:00

  • Evaluating Asthma-Related Expenses And Health Care Resource Utilization Among Children In The United States Medicaid Population

    May 1, 2016, 00:00

  • DESCRIPTIVE ANALYSIS OF ADVERSE EVENTS ASSOCIATED WITH CYCLOOXYGENASE-2 (COX-2) INHIBITORS USING FAERS 1997–2015

    May 1, 2016, 00:00

  • Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer- Systematic Review and Trial Level Meta-Analysis

    May 1, 2016, 00:00

  • DELIVERING ACTIONABLE RESULTS FOR OBSERVATIONAL STUDIES THROUGH RAPID EVALUATION PROCESSES

    May 1, 2016, 00:00

  • Oncology Drugs Lag Between Europe and other Countries- Comparaison between EMA and others Agencies (FDA, Health Canada, TGA, and Swissmedic)

    May 1, 2016, 00:00

  • EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL VACCINE- OVERVIEW OF THE LITERATURE FOR INCORPORATION PURPOSES

    May 1, 2016, 00:00

  • Comparing the Expanded Disability Status Scale Versus the Multiple Sclerosis Functional Composite As Clinical Endpoints in Multiple Sclerosis Clinical Trials- A Quantitative Meta-Analysis

    May 1, 2016, 00:00

  • Assessing The Economic Burden And Health Care Resource Utilization Of Us Veterans With Chronic Obstructive Pulmonary Disease

    May 1, 2016, 00:00

  • A PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF FOLIC ACID AND/OR VITAMIN B COMPLEX ON HEPATITIS C INFECTED PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN

    May 1, 2016, 00:00

  • HEALTH INSECURITY AND SOCIAL PROTECTION- PATHWAYS, GAPS, AND THEIR IMPLICATIONS ON HEALTH OUTCOMES AND POVERTY

    May 1, 2016, 00:00

  • Measuring Treatment Satisfaction in Erectile Dysfunction- Use of A Person-Item Map

    May 1, 2016, 00:00

  • Estimation Of Direct And Indirect Costs Associated With Asthma And Copd- A Canadian Employers Perspective

    May 1, 2016, 00:00

  • Humanistic Burden After Renaltransplantation In Europe- Systematic Literature Review

    May 1, 2016, 00:00

  • Oncologic Outcomes Of Metformin In Patients With Non-Metastatic Colon Cancer And Type 2 Diabetes In South Korea Using Nationwide Database

    May 1, 2016, 00:00

  • Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis

    May 1, 2016, 00:00

  • Impact of Bupivacaine Liposomal Injectable Suspension on Hospital Length of Stay and Home Discharge among Medicare Patients Undergoing Total Knee Arthroplasty

    May 1, 2016, 00:00

  • Demographic and Socioeconomic Characteristics that Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients

    May 1, 2016, 00:00

  • AN ASSESSMENT OF THE VALIDITY AND RESPONSIVENESS OF THE ICECAP-O IN A MULTICENTRE RANDOMIZED CONTROLLED TRIAL OF BLOOD PRESSURE MANAGEMENT

    May 1, 2016, 00:00

  • EXTERNAL VALIDATION OF HEALTH ECONOMIC MODELS FOR COMPLEX CHRONIC DISEASES- LESSONS FROM A POPULATION MODEL FOR DIABETIC RETINOPATHYHerring W., Mladsi D.M. , RTI Health Solutions, Research Triangle Park, NC, USA

    May 1, 2016, 00:00

  • CLINICAL AND ECONOMIC OUTCOMES OF FIBRIN SEALANTS (EVICEL AND TISSEEL) USED FOR HEMOSTASIS IN CORONARY ARTERY BYPASS GRAFTING SURGERY IN THE UNITED STATES

    May 1, 2016, 00:00

  • The Burden Of Atopic Dermatitis In Adults- Results From The 2013 United States National Health And Wellness Survey (Nhws)

    May 1, 2016, 00:00

  • The Concentration of Health Care Expenditure of a Colombian Public Health Insurance Company

    May 1, 2016, 00:00

  • SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF ALTERNATE IMMUNIZATION STRATEGIES TO CONTROL MENINGOCOCCAL MENINGITIS

    May 1, 2016, 00:00

  • Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes

    May 1, 2016, 00:00

  • The Relationship between Preventive Care Visits and School Absences among Children with Asthma

    May 1, 2016, 00:00

  • A Study To Determine The Economic Impact Of Major Depressive Disorder In Colombia

    May 1, 2016, 00:00

  • SYSTEMATIC REVIEW OF EFFICACY AND SAFETY OF DULAGLUTIDE COMPARED WITH OTHER ANTIDIABETIC DRUGS

    May 1, 2016, 00:00

  • IMPROVING THE CLINICAL PRACTICE GUIDELINES- WHY INCLUDE PSYCHOLOGICAL EVALUATION AND INTERVENTION?

    May 1, 2016, 00:00

  • THE UPTAKE OF BIOSIMILAR INFLIXIMAB BY ENGLISH ACUTE TRUSTS

    May 1, 2016, 00:00

  • Health Care Inequality And Business Cycles In Japan

    May 1, 2016, 00:00

  • DIETARY SUPPLEMENT USE, KNOWLEDGE, AND PERCEPTIONS AMONGST PHARMACY STUDENTS

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES- A US THIRD-PARTY PAYER PERSPECTIVE

    May 1, 2016, 00:00

  • B.E.S.T. Asthma Program (Breathe easy. Start today.®)- A Primary Care-Based Program For Dispensing Asthma Medication and Devices Reduces Acute Hospitalization and Expenditures in Medicaid Subjects

    May 1, 2016, 00:00

  • Table of Contents

    May 1, 2016, 00:00

  • FACTORS AFFECTING ADOPTION OF COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM

    May 1, 2016, 00:00

  • Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs

    May 1, 2016, 00:00

  • Reducing Young Invincibles’ Health Care Spending through the Aca Expansion of Dependent Coverage

    May 1, 2016, 00:00

  • DEVELOPING GUIDELINES FOR MIGRATING THE ACTS, A PAPER PRO, TO WEB FORMAT

    May 1, 2016, 00:00

  • Treatment with interferon beta-1a in brazil is associated with fewer hospitalizations due to relapse, better adherence and a better response compared to other platform therapies

    May 1, 2016, 00:00

  • MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS

    May 1, 2016, 00:00

  • An Analysis Of The Criteria Used In Existing Or Proposed Mcda Models

    May 1, 2016, 00:00

  • Demographic Variance of Inpatient Hospitalizations from Stroke in the State of Missouri from 2000-2012

    May 1, 2016, 00:00

  • HTA IN BRAZIL- WHAT HAS CHANGED SINCE THE CREATION OF CONITEC?

    May 1, 2016, 00:00

  • ESTIMATING HOSPITAL COSTS FOR MEDICARE PATIENTS UNDERGOING TOTAL KNEE ARTHROPLASTY USING PREMIER CHARGEMASTER DATA

    May 1, 2016, 00:00

  • Psychiatric Safety Profile Of Suvorexant, A First-In-Class Orexin Receptor Antagonist

    May 1, 2016, 00:00

  • DEVELOPMENT OF THE IMPACT OF OPIOID ON BIOPYSCHOSOCIAL-SPIRITUAL FUNCTIONS (IOBPSS) SCALE IN ACUTE AND CHRONIC PAIN

    May 1, 2016, 00:00

  • Associated Factors with Graft Loss in Kidney Transplantation Patients who used Maintenance Immunosuppressive Regimens Containing Cyclosporine or Tacrolimus in Sus

    May 1, 2016, 00:00

  • Types of Chronic Conditions Combinations and Initial Cancer Treatment among Elderly Medicare Beneficiaries with Localized Prostate Cancer

    May 1, 2016, 00:00

  • Assesment of the Medical and Social Benefits of Incretin-Based Therapy

    May 1, 2016, 00:00

  • Comparative Estimation of the Out-of-Pocket Expenses and Indirect Costs Associated Ovarian Cancer and Parkinson’s Disease

    May 1, 2016, 00:00

  • Revisiting The Performance Of Continuity Correction Methods In Meta-Analysis Of Sparse Data

    May 1, 2016, 00:00

  • Awareness and Impact of International Normalized Ratio Monitoring in Ongoing Anticoagulation Therapy in Cardiac Patients

    May 1, 2016, 00:00

  • EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF TWO ELECTRONIC DAILY DIARIES DEVELOPED TO ASSESS BREAST PAIN/TENDERNESS AND VAGINAL BLEEDING/SPOTTING IN POSTMENOPAUSAL WOMEN ON HORMONE THERAPY

    May 1, 2016, 00:00

  • A Prevalence Study on Gestational Hypertension and Associated Complications in Pregnant Women

    May 1, 2016, 00:00

  • EVALUATION OF BRAZILIAN CLINICAL GUIDELINES PRODUCED BY THE MINISTRY OF HEALTH IN RELATION TO THE AGREE II CRITERIA

    May 1, 2016, 00:00

  • ECONOMIC EVALUATION OF ERTAPENEM IN THE TREATMENT OF SEPSIS FROM ENTEROBACTERIA PRODUCING BETA-LACTAMASES OF EXTENDED SPECTRUM (BLEES) AT THE MEXICO CHILDREN’S HOSPITAL “FEDERICO GOMEZ”

    May 1, 2016, 00:00

  • Comparative Efficacy And Tolerability Of Lurasidone For The Management Of Bipolar Depression- A Systematic Review And Network Meta-Analysis

    May 1, 2016, 00:00

  • Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy

    May 1, 2016, 00:00

  • Emergency Department Visits Associated With Ankle Sprains In The United States

    May 1, 2016, 00:00

  • Evaluation of Asthma Outcomes in Older and Younger Adults

    May 1, 2016, 00:00

  • CLINICIAN ENGAGEMENT IN THE NIH HEALTH CARE SYSTEMS RESEARCH COLLABORATORY

    May 1, 2016, 00:00

  • DIRECT OUT OF POCKET EXPENDITURE FOR MEDICAL CARE OF TYPE 1 DIABETIC PATIENTS ATTENDING A TERTIARY CARE HOSPITAL

    May 1, 2016, 00:00

  • Impact of Depression on Health Expenses and Medical Utilization in Adults with Migraine

    May 1, 2016, 00:00

  • THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY

    May 1, 2016, 00:00

  • Reevaluating the Value of Ezetimibe in the United States For Patients with History of Cvd Based on the Improve-It Result

    May 1, 2016, 00:00

  • Impact of Dry Eye Disease on Quality of Life, Work Productivity, Daily Activities, and Health Care Resource Use in a Survey of 74,095 American Adults

    May 1, 2016, 00:00

  • Preferences For Pediatric Attention-Deficit/Hyperactivity Disorder Management And Medication Changes And Caregiver-Reported Improvement Over A 6-Month Follow-Up

    May 1, 2016, 00:00

  • CHARACTERIZATION OF MALE AND FEMALE USERS OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

    May 1, 2016, 00:00

  • PCPA/CDR/PCODR CHANGES AND IMPACT TO MARKET ACCESS IN CANADA

    May 1, 2016, 00:00

  • Caregiver Burden In The United States Workfor Health Care Resource Utilization And Quality of Life

    May 1, 2016, 00:00

  • Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease in Brazil

    May 1, 2016, 00:00

  • ESTIMATION OF HEALTH BENEFITS FROM SUCCESSFUL PREVENTION OF AN ILLNESS- METHODS AND EXAMPLES

    May 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Palbociclib and other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

    May 1, 2016, 00:00

  • Unlocking Smartphone Potential in Health Care by Providing Smartphones to Patients- A Systematic Review

    May 1, 2016, 00:00

  • Indirect Treatment Comparison Of Cabazitaxel For Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With A Docetaxel-Containing Regimen

    May 1, 2016, 00:00

  • Examining Length of Stay and Home Discharge when Using Bupivacaine Liposomal Injectable Suspension in Medicare Patients Undergoing Total Hip Arthroplasty

    May 1, 2016, 00:00

  • Patient Preference for Display of Electronic Patient-Reported Outcomes- Wording Emphasis, Question Format, and Navigation Button Placement

    May 1, 2016, 00:00

  • Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain

    May 1, 2016, 00:00

  • Knowledge and Practices Related to Rational Use of Antibiotics in Panama

    May 1, 2016, 00:00

  • ANALYSIS OF TRENDS IN UTILIZATION AND COST OF INSULIN IN THE UNITED STATES AND CANADA

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR AGAINST LOPINAVIR/RITONAVIR IN THE TREATMENT OF PEOPLE LIVING WITH HIV IN PERU

    May 1, 2016, 00:00

  • Challenges in Using MCDA for Reimbursement Decisions on New Medicines?

    Mar 1, 2016, 00:00

  • Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes

    Mar 1, 2016, 00:00

  • Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices- Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

    Mar 1, 2016, 00:00

  • Patient-Centered Outcomes of Medication Adherence Interventions- Systematic Review and Meta-Analysis

    Mar 1, 2016, 00:00

  • Copyright/Subscription

    Mar 1, 2016, 00:00

  • Estimating the Cost-Effectiveness of Implementation- Is Sufficient Evidence Available?

    Mar 1, 2016, 00:00

  • Erratum

    Mar 1, 2016, 00:00

  • Instructions for Authors

    Mar 1, 2016, 00:00

  • Examining the Value of Menopausal Symptom Relief Among US Women

    Mar 1, 2016, 00:00

  • Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection- A Systematic Review

    Mar 1, 2016, 00:00

  • The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index

    Mar 1, 2016, 00:00

  • Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines- A Systematic Review

    Mar 1, 2016, 00:00

  • Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods- Does Dimension Order Impact on Health State Values?

    Mar 1, 2016, 00:00

  • Improving Adherence to Cardiovascular Therapies- An Economic Evaluation of a Randomized Pragmatic Trial

    Mar 1, 2016, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia

    Mar 1, 2016, 00:00

  • Preferences for Prostate Cancer Outcomes- A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer

    Mar 1, 2016, 00:00

  • Responsiveness to Change in PROMIS Pediatric Asthma Study

    Mar 1, 2016, 00:00

  • Comprehensively Measuring Health-Related Subjective Well-Being- Dimensionality Analysis for Improved Outcome Assessment in Health Economics

    Mar 1, 2016, 00:00

  • The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan

    Mar 1, 2016, 00:00

  • Valuing Treatments for Parkinson Disease Incorporating Process Utility- Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales

    Mar 1, 2016, 00:00

  • Table of Contents

    Mar 1, 2016, 00:00

  • Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness

    Mar 1, 2016, 00:00

  • Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States

    Mar 1, 2016, 00:00

  • Survival or Mortality- Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?

    Mar 1, 2016, 00:00

  • Expanding Health Technology Assessments to Include Effects on the Environment

    Mar 1, 2016, 00:00

  • A Simple and Practical Index to Measure Dementia-Related Quality of Life

    Jan 1, 2016, 00:00

  • Copyright/Subscription

    Jan 1, 2016, 00:00

  • Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients

    Jan 1, 2016, 00:00

  • The Parity Paradigm- Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

    Jan 1, 2016, 00:00

  • Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases- A Systematic Review of the Literature (the PROCHID Study)

    Jan 1, 2016, 00:00

  • Thirty Years of Media Coverage on High Drug Prices in the United States—A Never-Ending Story or a Time for Change?

    Jan 1, 2016, 00:00

  • Table of Contents

    Jan 1, 2016, 00:00

  • Instructions for Authors

    Jan 1, 2016, 00:00

  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2016, 00:00

  • Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer’s Disease

    Jan 1, 2016, 00:00

  • The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials- A Systematic Review

    Jan 1, 2016, 00:00

  • Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction- Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

    Jan 1, 2016, 00:00

  • Errata

    Jan 1, 2016, 00:00

  • Cost-Effectiveness of Integrating a Clinical Decision Rule and Staged Imaging Protocol for Diagnosis of Appendicitis

    Jan 1, 2016, 00:00

  • Changes in Quality of Life Associated with Complications of Diabetes- Results from the ADVANCE Study

    Jan 1, 2016, 00:00

  • The “Efficacy-Effectiveness Gap”- Historical Background and Current Conceptualization

    Jan 1, 2016, 00:00

  • The Cost of Increasing Physical Activity and Maintaining Weight for Midlife Sedentary African American Women

    Jan 1, 2016, 00:00

  • Concept Elicitation Within Patient-Powered Research Networks- A Feasibility Study in Chronic Lymphocytic Leukemia

    Jan 1, 2016, 00:00

  • An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

    Jan 1, 2016, 00:00

  • Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer- A Survey Capturing Experiences from a Diverse Sample of UK Patients

    Dec 1, 2015, 00:00

  • Table of Contents

    Dec 1, 2015, 00:00

  • Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal- An Application from the Norwegian Cervical Cancer Screening Program

    Dec 1, 2015, 00:00

  • Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

    Dec 1, 2015, 00:00

  • Beware of Kinked Frontiers- A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening

    Dec 1, 2015, 00:00

  • Time Series Analysis on the Impact of Generic Substitution and Reference Pricing on Antipsychotic Costs in Finland

    Dec 1, 2015, 00:00

  • A Quality-Adjusted Life-Year Measure for Multiple Sclerosis- Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure

    Dec 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology- The BEST II Study

    Dec 1, 2015, 00:00

  • Development of the Treatment Inventory of Costs in Psychiatric Patients- TIC-P Mini and Midi

    Dec 1, 2015, 00:00

  • Economic Evaluation of Cinacalcet in the United States- The EVOLVE Trial

    Dec 1, 2015, 00:00

  • Health Utility Values Associated with Surgical Site Infection- A Systematic Review

    Dec 1, 2015, 00:00

  • A Vision “Bolt-On” Item Could Increase the Discriminatory Power of the EQ-5D Index Score

    Dec 1, 2015, 00:00

  • Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis

    Dec 1, 2015, 00:00

  • Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs- A Simulation Study

    Dec 1, 2015, 00:00

  • Copyright/Subscription

    Dec 1, 2015, 00:00

  • HIV Treatment in Resource-Limited Environments- Treatment Coverage and Insights

    Dec 1, 2015, 00:00

  • Erratum

    Dec 1, 2015, 00:00

  • Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data

    Dec 1, 2015, 00:00

  • Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems- Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure

    Dec 1, 2015, 00:00

  • HIQA’s CEA of Breast Screening- Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not

    Dec 1, 2015, 00:00

  • Quality of Life and Asthma Symptom Control- Room for Improvement in Care and Measurement

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women

    Dec 1, 2015, 00:00

  • Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis

    Dec 1, 2015, 00:00

  • Citizens’ Perspectives on Disinvestment from Publicly Funded Pathology Tests- A Deliberative Forum

    Dec 1, 2015, 00:00

  • The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands

    Dec 1, 2015, 00:00

  • Using Generalized Linear Mixed Models to Evaluate Inconsistency within a Network Meta-Analysis

    Dec 1, 2015, 00:00

  • Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa

    Dec 1, 2015, 00:00

  • Instructions for Authors

    Dec 1, 2015, 00:00

  • The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease- A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data

    Dec 1, 2015, 00:00

  • Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey

    Nov 1, 2015, 00:00

  • Virtual Consultation System To Enable Rare Diseases Diagnosis

    Nov 1, 2015, 00:00

  • Healthcare Burden and Economic Cost of Hospitalisation During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) in France

    Nov 1, 2015, 00:00

  • Assessment of The Association Between Sleep Behaviors and Experiential Outcomes Among A Multinational Adult Population

    Nov 1, 2015, 00:00

  • Liste-En-Sus Reform In France - What are The Consequences?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Bemiparin Used As Acute Treatment For Deep Venous Thrombosis Without Pulmonary Embolism

    Nov 1, 2015, 00:00

  • Social Burden of Chronic Hcv Infection in Patients with Hepatocellular Carcinoma

    Nov 1, 2015, 00:00

  • Torsade De Pointes And Qt Prolongation Could Result From Desloratadine Anti-Allergy Treatment

    Nov 1, 2015, 00:00

  • Evalución Económica Completa Del Sistema De Terapia De Radiación Con Rayos X Para El Tratamiento Cáncer De Próstata De Alto Riesgo En México

    Nov 1, 2015, 00:00

  • Defining Market Access in Brazil- the Pharma Professionals’ Perspective

    Nov 1, 2015, 00:00

  • Market Access of Atmps- Overview and Expected Challenges

    Nov 1, 2015, 00:00

  • Current Treatment Patterns In Patients With Metastatic Melanoma- A Retrospective Claims Database Analysis In The United States (Us)

    Nov 1, 2015, 00:00

  • Examining Health System And Resource Utilization And Medical Management Of Patients Idiopathic Pulmonary Fibrosis In Ontario- A Preliminary Analysis

    Nov 1, 2015, 00:00

  • Economic and Clinical Impact of Secondhand Smoking In Korea

    Nov 1, 2015, 00:00

  • Evaluacion Sobre Medicamentos y Actos Medicos Cubiertos Financieramente Por Resolucion Judicial- Fnr

    Nov 1, 2015, 00:00

  • Predictors Of Utility Over Time Among Patients With Treatment-Naïve Advanced Melanoma From The Phase 3 Checkmate 066 Trial

    Nov 1, 2015, 00:00

  • The Use of Real World Evidence to Influence Practi A Systematic Review of Cprd Studies In English Guidances And Guidelines

    Nov 1, 2015, 00:00

  • Challenges to The Economic Modelling of Macular Oedema Due to Retinal Vein Occlusion And Diabetes

    Nov 1, 2015, 00:00

  • The Cost of Non-Severe Hypoglycaemia In Europe

    Nov 1, 2015, 00:00

  • Assessing the Public Health Impact and Cost Effectiveness of Pneumococcal Vaccines for Adults 65 Years of Age in Colombia

    Nov 1, 2015, 00:00

  • Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

    Nov 1, 2015, 00:00

  • Disease Progression In Rheumatoid Arthritis- Key Element for Cost-Effectiveness Modelling

    Nov 1, 2015, 00:00

  • Burden of Disease of Diabetes Mellitus Typ-2 In Austria

    Nov 1, 2015, 00:00

  • Acessibilidade De Obesos M”Rbidos Usuários Do Sistema Público De Saúde No Brasil

    Nov 1, 2015, 00:00

  • Societal Burden And Impact On Health Related Quality Of Life (Hrqol) Of Non-Small Cell Lung Cancer (Nsclc) In Europe

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Esomeprazole Compared With Other Ppis Currently Reimbursed In Poland In The Treatment of Gerd

    Nov 1, 2015, 00:00

  • Direct Evidence Versus Lack of Direct Evidence and the Impact on HTA Acceptance

    Nov 1, 2015, 00:00

  • Hospitalization Cost and Length of Stay Associated with Ophthalmological Surgery Depending on the Diabetic Status

    Nov 1, 2015, 00:00

  • Reduction In C-Reactive Protein With Biologic Drugs In Rheumatoid Arthritis and Spondylitis Patients In German Rheumatologist Practices

    Nov 1, 2015, 00:00

  • The Epidemiological and Cost Burden of Herpes Zoster (Hz) and Post-Herpetic Neuralgia (Phn) in the Uk

    Nov 1, 2015, 00:00

  • Transparency and Reproducibility of Supplementary Search Methods in Nice Single Technology Appraisal Manufacturer Submissions

    Nov 1, 2015, 00:00

  • Factors Associated With The Duration Of Anticoagulation Therapy Following Acute Vte In England In General Practi An Observational Study Using Cprd-Hes Databases

    Nov 1, 2015, 00:00

  • The Importance of the Communicator for an Integrated Care Program - A Comparative Preference Analysis with Discrete Choice Experiments

    Nov 1, 2015, 00:00

  • Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran

    Nov 1, 2015, 00:00

  • Recent Hypoglycemia Episodes Are Associated With Poorer Quality Of Life, Healthcare Resource Use, And Work Impairment Among Patients With Type II Diabetes In Brazil

    Nov 1, 2015, 00:00

  • Assessment Of Knowledge And Awareness Regarding Asthma Among School Teachers In Quetta

    Nov 1, 2015, 00:00

  • A Study of Knowledge, Attitude And Practice of Community Pharmacists Towards Adverse Drug Reaction Reporting Monitoring

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey

    Nov 1, 2015, 00:00

  • Economic Impact of A Volumetric Infusion Pump (Infusomat® Space) + Central Alarm Management (One View), In The Risk Prevention In Infusion Therapy In The Intensive Care Unit (Icu) In Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A 13-Valent Conjugate Pneumococcal Vaccination Program In Copd Patients Aged 50+ Years In Spain

    Nov 1, 2015, 00:00

  • Assessment of Compliance among Patients with Arthritis

    Nov 1, 2015, 00:00

  • Estimating The Public Health Impact Of A Vaccination Programme With A Nonavalent Hpv Vaccine In Germany

    Nov 1, 2015, 00:00

  • Influence Of The Method Of Analysis On Estimates Of Qaly Treatment Differen Phase Iii Trial Of Vinflunine Versus Best Supportive Care In Patients With Tccu

    Nov 1, 2015, 00:00

  • The Burden of Rheumatoid Arthritis in Russia

    Nov 1, 2015, 00:00

  • The Efficiency Path- An Estimation of Cost-Effectiveness Thresholds for 185 Countries Based on Per Capita Health Expenditures and Life Expectancy

    Nov 1, 2015, 00:00

  • Caracterización de Pacientes Con Múltiples Enfermedades Crónicas desde la Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00

  • Anaesthesia In Developing Countries

    Nov 1, 2015, 00:00

  • Estimación de Cambios en la Calidad de Vida Debido al Uso de Ocriplasmina en Pacientes Con Tracción Vitreomacular en Colombia

    Nov 1, 2015, 00:00

  • Current Clinical Practice Correspondence With Treatment Guidelines In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2015, 00:00

  • Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure

    Nov 1, 2015, 00:00

  • Development and Validation of a Questionnaire Assessing the fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases

    Nov 1, 2015, 00:00

  • Systematic Literature Review (Slr) And Network Meta-Analysis (Nma) Of Tenofovir/Emtricitabine (Tdf/Ftc) And Abacavir/Lamivudine (Abc/3tc) Backbone Regimens For Hiv-1

    Nov 1, 2015, 00:00

  • Results of the Eq-5d-3l Valuation Project for Ireland

    Nov 1, 2015, 00:00

  • Development Of A Model To Provide Insight In The Value Of Fibrinogen Concentrate For Treating Excessive Bleedings During Complex Cardiovascular Surgery

    Nov 1, 2015, 00:00

  • Comparison Of Kras Tested And Not-Tested Metastatic Colorectal Cancer (Mcrc) Patient Cohorts In Europe

    Nov 1, 2015, 00:00

  • Assessment Of Patient-Reported Health Status In Pulmonary Arterial Hypertension Patients Treated With Riociguat- 2-Year Results From The Patent-2 Extension Study

    Nov 1, 2015, 00:00

  • Contrasting Model Predicted Life Expectancy In Patients With Type 2 Diabetes Across Different Mortality Risk Prediction Models Versus Data From The Canadian Chronic Disease Surveillance System

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Alteplase In The Treatment of Acute Ischaemic Stroke In Mexico

    Nov 1, 2015, 00:00

  • Abobotulinumtoxin A In The Management of Cervical Dystonia In The United Kingdom- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Análisis De Impacto Presupuestal De Detemir En Pacientes Diabéticos Tratados Con Insulinas Análogas

    Nov 1, 2015, 00:00

  • Overview of Nub Process for In-Patient Drugs and Devices In German

    Nov 1, 2015, 00:00

  • Matching-Adjusted Indirect Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)- Updated Analysis

    Nov 1, 2015, 00:00

  • Validation of A Markov Model for Economic Evaluation of Screening and Preventive Interventions In Alzheimer’s Disease In Denmark

    Nov 1, 2015, 00:00

  • Impact Of Nocturia On Quality Of Life – Mapping Of Sf-12 To Utility Values Using Clinical Trial Data

    Nov 1, 2015, 00:00

  • Cost And Resource Utilization Of Uncontrolled And Persistent Asthma In Canada- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Utilização Do Escore De Propensão Na Comparação De Duas Opç’es Terapêuticas Em Pacientes Com Carcinoma Epiderm”Ide De Cabeça E Pescoço, Brasil 1998-2008

    Nov 1, 2015, 00:00

  • Predictors of Positive Decision Outcomes by the Cancer Drugs Fund

    Nov 1, 2015, 00:00

  • Patient Preferences for Attributes of Type 2 Diabetes Mellitus (T2dm) Treatments In Spain

    Nov 1, 2015, 00:00

  • Impact of Healthcare Reforms on Pricing and Reimbursement In Turkey

    Nov 1, 2015, 00:00

  • Application Of Asco Value Framework Evaluations Of Net Health Benefit For Oncology Drugs Launched In The United States Between 2013 And 2015

    Nov 1, 2015, 00:00

  • Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome- A United States Perspective

    Nov 1, 2015, 00:00

  • Disproportionality Measures Used in Signal Detection- An Assessment on Pharmacovigilance Adverse Event Reporting System Data

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life (Hrqol) Measures In Autosomal Dominant Polycystic Kidney Disease (Adpkd)

    Nov 1, 2015, 00:00

  • Hiv Patient Preferences for Simplified Treatment Regimens

    Nov 1, 2015, 00:00

  • Economic Evaluation of The Aranesp Application for Anemia Correction In Pathients With Chronical Renal Failure on Hemodialysis or Peritoneal Dialysis In Russia

    Nov 1, 2015, 00:00

  • Costo Efectividad De Múltiples Alternativas Diagn”Sticas En Pacientes Con Sospecha De Cáncer De Pulm”N En Colombia

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)- An In-Depth Analysis Of Eq-5d Data From The Prevail Trial

    Nov 1, 2015, 00:00

  • Impact of Poverty on Multidimensional Infant Mortality Rate In Brazil

    Nov 1, 2015, 00:00

  • Economic Assessment of Eltrombopag In The Treatment of Thrombocytopenia In Italy

    Nov 1, 2015, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Different Variants Of Balanced Crystalloids During Infusion Therapy

    Nov 1, 2015, 00:00

  • The German Amnog Drug Reimbursement Process- Factors Associated With Gba-Decisions About The Additional Benefit

    Nov 1, 2015, 00:00

  • The Opportunities Of Internet Technology And Telemedicine In Interaction Between Doctor And Patient

    Nov 1, 2015, 00:00

  • Applied Comparison of Meta-Analysis Techniques

    Nov 1, 2015, 00:00

  • The 5-Years European Price Stability Awarded to Innovative Medicines- Is It Verified In Practice?

    Nov 1, 2015, 00:00

  • Japanese Population Norms for Preference-Based Measures- Eq-5d-3l, Eq-5d-5l, And Sf-6d

    Nov 1, 2015, 00:00

  • Survival and Rehospitalization After a First Hospitalization for Heart Failure- a Nationwide Population-Based Cohort Study using the French Egb Database

    Nov 1, 2015, 00:00

  • Hospitalisations Among Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) Receiving Chemotherapy in Germany- A Retrospective Chart Review

    Nov 1, 2015, 00:00

  • Quality of Life Instruments used to Measure Job-Related Stress- a Systematic Review

    Nov 1, 2015, 00:00

  • Study on Cost-Effectiveness Analysis For Ulcerative Colitis Treatment- A Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study

    Nov 1, 2015, 00:00

  • Potential Economic Impact Of Inhalation Errors Due To Device Switch In Patients With Chronic Obstructive Pulmonary Disease And Asthma

    Nov 1, 2015, 00:00

  • Building a Real World Data Network to Support Access to Oncology Medicines in Fran the Personalised Reimbursement Models Initiative

    Nov 1, 2015, 00:00

  • Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis In Iran- Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Prevention and Treatment of Missing Data in Real World Research

    Nov 1, 2015, 00:00

  • The Expansion of Use of Discounted Prices for International Reference Pricing Purposes

    Nov 1, 2015, 00:00

  • Network Meta-Analysis (NMA) to Assess Relative Efficacy Measured as Percentage of Patients Treated to HbA1c Target with Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (M ...

    Nov 1, 2015, 00:00

  • Estimacion Del Costo De Tratamiento De Un Evento Moderado Versus Uno Severo De Hipoglucemia En Pacientes Con Diabetes Mellitus Tipo 2 En Mexico Desde La Opinion De Expertos

    Nov 1, 2015, 00:00

  • Mapping of the 16-Item Sort form Version of the Menopause Cervantes Health-Related-Quality-of-Life Scale onto the Eq-5d-3l

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Quadrivalent Influenza Vaccine in Spain

    Nov 1, 2015, 00:00

  • Systematic Review of Esomeprazole for The Treatment of Gastroesophageal Reflux Disease

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Severe Or Uncontrolled Asthma

    Nov 1, 2015, 00:00

  • Clinical-Economic Modeling Analysis Of Human Papillomavirus (Hpv) Co-Testing With Genotyping Versus Primary Hpv Testing For Cervical Cancer Screening

    Nov 1, 2015, 00:00

  • Assessment of Dental Status and Perception Towards Oral Health Among Pharmacy Students In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Cost Of Multimorbidity- The Influence Of Ambulatory Pharmaceutical And Hospital Expenditure

    Nov 1, 2015, 00:00

  • What is the Most Cost-Effective way to Set-Up Organised Cervical Cancer Screening in France? a Budget Impact Analysis

    Nov 1, 2015, 00:00

  • The impact of the u.s. Odac decision on avastin prescribing for metastatic breast cancer

    Nov 1, 2015, 00:00

  • Economic Aspects in the Management of Diabetes in Italy

    Nov 1, 2015, 00:00

  • Time Trade-Off Utility Values in Mild and Severe Primary Dysmenorrhea

    Nov 1, 2015, 00:00

  • TRANSLATION AND LINGUISTIC VALIDATION OF THE MODIFIED MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM - TOTAL SYMPTOM SCORE (MMPN-SAF TSS) FOR USE IN 26 COUNTRIES

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00

  • Psychiatric Healthcare Utilization and Related Costs In Newly Diagnosed Individuals With Autism Spectrum Disorder (Asd) In Quebec (Canada)

    Nov 1, 2015, 00:00

  • Diabetes Conversation Maps and Health Outcomes- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Colon Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00

  • Medical Devices For Patients With Incontinence. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Identification of Subgroups With Low Rates of Weight Loss In Israel

    Nov 1, 2015, 00:00

  • Considerations for the Adoption of the who-Choice Cost-Effectiveness Threshold in Latin America

    Nov 1, 2015, 00:00

  • The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has

    Nov 1, 2015, 00:00

  • Can Data Simulation Help Evaluate Hta Outcomes Over Time and Facilitate Early Decision-Making? a Case Study of Ticagrelor in Acute Coronary Syndrome in the Uk

    Nov 1, 2015, 00:00

  • Cancer Drug Funding Decisions in the UK- Innovation And Value in the Biologics Era

    Nov 1, 2015, 00:00

  • Potentially inadequate Medication (Pim) Effects on Adverse Drug Events (Ades) and Costs- Hospital Universitario Austral (Hua)

    Nov 1, 2015, 00:00

  • Epidemiology and Current Treatment of Neuromyelitis Optica- A Systematic Review

    Nov 1, 2015, 00:00

  • Model-Based Techniques In The Early Phases of The Medical Device Development- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Identifying Practical Gaps to Comply with Cost-Effectiveness Guideline in Selecting Comparators in South Korea

    Nov 1, 2015, 00:00

  • Nice Patient Access Schemes – A Who, What, Why, When and How

    Nov 1, 2015, 00:00

  • Mapping the Beck Depression Inventory to the Eq-5d-3l in Patients with Depressive Disorders

    Nov 1, 2015, 00:00

  • Diareg - Diabetes Register Including Patient Reported Outcomes

    Nov 1, 2015, 00:00

  • The Relationship Between Knowledge and Performan The Case of Iran Community Pharmacies

    Nov 1, 2015, 00:00

  • Cost Study of Assisted Reproductive Technologies in Ukraine

    Nov 1, 2015, 00:00

  • Nutritional Aspects And Disinformation In Liver Disease- A Questionnaire-Based Survey In Italian Patients

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for the Argentinian Health System

    Nov 1, 2015, 00:00

  • Consequences Of Biomarker Analysis On The Cost-Effectiveness Of Cetuximab In Combination With Irinotecan Based Chemotherapy For First-Line Treatment Of Metastatic Colorectal Cancer. Stratified Medicine At Work?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Conjugate Pneumococcal Vaccination In Croatia

    Nov 1, 2015, 00:00

  • Investigating The Impact of Contemporary Risk Factors for Diabetes Complications and Their Evolution on Risk Prediction Using The Ukpds 82 Equations

    Nov 1, 2015, 00:00

  • Impact of Clerkship Attachments on Students’ Attitude Towards Pharmaceutical Care In Ethiopia

    Nov 1, 2015, 00:00

  • Estimation of Direct Medical Costs Associated with Treatment of Metastatic Melanoma in Switzerland

    Nov 1, 2015, 00:00

  • Epidemiological Data Used In Rotavirus Vaccination Cost-Effectiveness Analysis In Europe- A Literature Review Update

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Brazil

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Deep Brain Stimulation (Dbs) In The Management Of Advanced Parkinson’s Disease- A Swedish Payer Perspective

    Nov 1, 2015, 00:00

  • The Under-Recognised Human and Economic Impact of Chronic Rhinosinusitis

    Nov 1, 2015, 00:00

  • Cost – Effectiveness Analysis Of Budesonid Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

    Nov 1, 2015, 00:00

  • Prevalnce of Cigrate Smooking And Allied Tobacco Products Among Universty Students In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction

    Nov 1, 2015, 00:00

  • Do European Patients Have A Shared Preference For The Benefits And Risks Of Medicines?

    Nov 1, 2015, 00:00

  • A New Pace for the Smc?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

    Nov 1, 2015, 00:00

  • Budgetary Implications Of Introducing The Gsk Ellipta Portfolio For Copd In The Uk

    Nov 1, 2015, 00:00

  • An Eq-5d-3l Value Set For Trinidad And Tobago

    Nov 1, 2015, 00:00

  • Calculating The Prevalence of Urea Cycle Disorders In The Eu5 Using An Incidence–Survival Model

    Nov 1, 2015, 00:00

  • Multiple To Single Transition Probability- Hcv-Based Example

    Nov 1, 2015, 00:00

  • Beliefs About Medicines In An Urban Community Health Center Hypertension Population

    Nov 1, 2015, 00:00

  • Establishing the Value of Emerging Biosimilars

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Patients Aged 65-84 Years With Co-Morbidities or Immunosuppression In Belgium

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Adalimumab for The Treatment of Moderate-To-Severe Ulcerative Colitis In Patients In Spain

    Nov 1, 2015, 00:00

  • Assessment of Effective Incentives for Blood Donations. How can citizens be Motivated to donate Blood?

    Nov 1, 2015, 00:00

  • Cost Analysis of the Diabetic Treatment in Italy- The Role of Vildagliptin vs. Other Therapeutic Options in Patients with Type 2 Diabetes with Renal Insufficiency

    Nov 1, 2015, 00:00

  • Effectiveness of The Antibiotic-Impregnated Catheters In Ventricular Drainage In Hydrocephalus Patients – A Systematic Review

    Nov 1, 2015, 00:00

  • Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders

    Nov 1, 2015, 00:00

  • Preliminary Study of Safety and Efficacy of Warfarin Versus Dabigatran in Atrial Fibrillation Patients in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00

  • Systematic Review Of Burden Of Cutaneous T-Cell Lymphoma

    Nov 1, 2015, 00:00

  • The Use of Propensity Score Matching Does Not Protect Against Regression Artifacts (Regression Towards The Mean)

    Nov 1, 2015, 00:00

  • Systematic Review of Economic Evaluations of Treatments In Epilepsy

    Nov 1, 2015, 00:00

  • Pangaea 2.0- State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod

    Nov 1, 2015, 00:00

  • Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Analysis of Health Services Utilization among Elderly in Slovenia

    Nov 1, 2015, 00:00

  • Methodological Changes In Burden of Infectious Disease Estimation- The Case of Pneumococcal Infection In Colombia

    Nov 1, 2015, 00:00

  • Ranking of Disease-Modifying Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Role of Economics, Health, And Social And Political Stability In Determining Health Outcomes

    Nov 1, 2015, 00:00

  • Expert Perspective on The Treatment of Functional Dyspepsia And Motility Disorders- A Multi-Criteria Decision Analysis Using The Analytic Hierarchy Process (Ahp)

    Nov 1, 2015, 00:00

  • Comparative Analysis of Expenditure of Drugs for Malignancy

    Nov 1, 2015, 00:00

  • ‘How Does that Make You feel?’ - the Ambiguity of Translating Depression

    Nov 1, 2015, 00:00

  • What does Copd Exacerbation Means for Patients and for Healthcare?

    Nov 1, 2015, 00:00

  • Evaluacion Economica De Los Principales Esteroides Intranasales Utilizados Para El Tratamiento De Pacientes Pediatricos Con Rinitis Alergica En Colombia

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Evaluation of Who/Inrud Prescribing Indicators and Prescribing Trend of Antibiotics in Accidents and Emergency Department, Bahawal Victoria Hospital, Bahawalpur, Pakistan

    Nov 1, 2015, 00:00

  • Cost-Utility of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Greece

    Nov 1, 2015, 00:00

  • Recommendations for Analysis of Patient Reported Outcomes (Pro) Efficacy Data When Evaluating Treatment Benefit

    Nov 1, 2015, 00:00

  • Calibration of Piecewise Markov Models Using a Change-Point Analysis Through an Iterative Convex Optimization Algorithm

    Nov 1, 2015, 00:00

  • Patients’ and Health Professionals’ Preferences Regarding Intravenous Vs Subcutaneous Drug Administration- A Literature Review

    Nov 1, 2015, 00:00

  • Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

    Nov 1, 2015, 00:00

  • Sistematic Review on Personal Predictors of Adherence to Medication. The Cumple-Q Scale

    Nov 1, 2015, 00:00

  • Analytical Representation of Utility Functions for Cervical Screening Strategies In Their Evaluation With “Cost-Utility” Method

    Nov 1, 2015, 00:00

  • Impact of Blood Transfusions on Hospital Length of Stay and Mortality- A Single-Center Experience

    Nov 1, 2015, 00:00

  • A Comparison of Market Access Evaluations for Type Ii Diabetes Mellitus In France and Germany- An Analysis Using The Prismaccess Database

    Nov 1, 2015, 00:00

  • Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

    Nov 1, 2015, 00:00

  • Dabigatran For The Treatment And Secondary Prevention Of Venous Thromboembolism

    Nov 1, 2015, 00:00

  • Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany

    Nov 1, 2015, 00:00

  • Mortality Due To Cardiovascular Disease In Colombia, 1998-2011

    Nov 1, 2015, 00:00

  • Delayed Enhancement Cardiac Magnetic Resonance to Refine Patient Selection For Implantable Cardioverter Defibrillator Therapy In Primary Prevention - An Exploratory Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Reduction in Costs over two years when Treating with Darunavir/Ritonavir Compared to Atazanavir/Ritonavir in the UK

    Nov 1, 2015, 00:00

  • Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

    Nov 1, 2015, 00:00

  • Profile of Colorectal Cancer Treatment Within The Brazilian Public Setting- Analysis Of Datasus Aq Database

    Nov 1, 2015, 00:00

  • Gasto de Bolsillo en Salud y Medicamentos en Chile- Análisis Comparativo de Los Periodos 1997, 2007 y 2012

    Nov 1, 2015, 00:00

  • Evaluation of Inhaler Perception and Preference of Spiromax®, Easyhaler®, And Turbuhaler® Devices (Finhaler)

    Nov 1, 2015, 00:00

  • From Diagnosis To Treatment And Survival- The Emotional Journey Of Patients With Breast Cancer

    Nov 1, 2015, 00:00

  • Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis- Interim Results From A Large Prospective, Observational Study

    Nov 1, 2015, 00:00

  • Orphan and Ultra-Orphan Technologies- European and Australian Payer Perceptions

    Nov 1, 2015, 00:00

  • Sobrevida De Cinco Anos E Fatores Associados Ao Câncer De Boca Para Pacientes Em Tratamento Oncol”Gico Ambulatorial Pelo Sistema Único De Saúde, Brasil

    Nov 1, 2015, 00:00

  • Cambio de Copago de Medicamentos en España y Desigualdad

    Nov 1, 2015, 00:00

  • A Systematic Review and Taxonomy of Economic Evaluations of Pharmaceuticals Licensed on The Basis of Uncontrolled Clinical Studies

    Nov 1, 2015, 00:00

  • Type II Diabetes Prevalence, Hypoglycemia Episodes, and Hba1C Control In Brazil

    Nov 1, 2015, 00:00

  • Tocilizumab in Methotrexate-Naïve Rheumatoid Arthritis – A Cost-Utility Model for Slovakia

    Nov 1, 2015, 00:00

  • Analysis of Nursing Activities And Health Care Need In Residential Social Care Institutions In Hungary

    Nov 1, 2015, 00:00

  • The Addition Of A Novel Colonoscope Device Improves Adenoma Detection In A German Screening Population Which May Result In Cost Savings Due To Fewer Cases Of Colorectal Cancer

    Nov 1, 2015, 00:00

  • Adapting Literature-Based Remission Rates for Chronic Spontaneous/Idiopathic Urticaria to The Needs of A Health Economic Model- A Kaplan-Meier Approach

    Nov 1, 2015, 00:00

  • Analisis de Costo Efectividad y Costo Utilidad del uso de Daclatasvir+Asunaprevir en el Tratamiento de Pacientes Con Hepatitis C en Colombia, Desde La Perspectiva Del Tercer Pagador

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Local Insufflation Of Warm Humidified Co2 During Open And Laparoscopic Colorectal Surgery

    Nov 1, 2015, 00:00

  • Reliability Of Manufacturers’ Budget Impact Estimates For Elimination Diet In Patients With Allergy To Cow’s Milk In Poland

    Nov 1, 2015, 00:00

  • Economic evaluations in infectious disease- which infections, what settings and what type of economic evaluations were reported in papers published in 2014?

    Nov 1, 2015, 00:00

  • Burden Of Epilepsy In Colombia

    Nov 1, 2015, 00:00

  • The Demographic Aspects of Turkish Chronic Hepatitis C Patients And The Treatment Initiation From A Physician’s Patient’s Point of View. First Interim Analysis of Turkish Data From Mosaic Study (An International Multicenter Prospective Obs ...

    Nov 1, 2015, 00:00

  • Payer Vs. Industry Views on Managed Entry Agreements

    Nov 1, 2015, 00:00

  • Evaluacion Economica De Leuprorelina 45 Mg En El Tratamiento De Cáncer De Prostata Avanzado

    Nov 1, 2015, 00:00

  • Copd Performance Indicators In An Integrated Care Program And Its Impact On Health Outcomes- The Recode Cluster Randomized Trial

    Nov 1, 2015, 00:00

  • Comparative Effectiveness Analysis Of Mab In Asthma- The Importance Of Exacerbation Definition

    Nov 1, 2015, 00:00

  • Evaluating the Safety Impact of Light Emitting Diode (LED) Guided Drug Picking in an Outpatient Pharmacy

    Nov 1, 2015, 00:00

  • Fda Breakthrough Status Versus Accelerated Approval – What’s the Difference?

    Nov 1, 2015, 00:00

  • Evaluacion Economica Del Manejo Farmacologico Del Paciente Con Hiperplasia Prostatica Benigna En Colombia

    Nov 1, 2015, 00:00

  • A Forma (in) Adequada do Aparato Vocal

    Nov 1, 2015, 00:00

  • Patient-Reported Outcomes within Health Technology Assessment Decision Making- Current Status and Implications for Future Policy

    Nov 1, 2015, 00:00

  • Clinical And Budget Impact Of Using A Molecular Test To Detect Kras Mutations In Metastatic Colorectal Cancer Patients In Denmark

    Nov 1, 2015, 00:00

  • 4+ Years of Amnog – Clinical Drivers for Successful Dossier Submissions in Oncology

    Nov 1, 2015, 00:00

  • Impacto Economico Del Tratamiento De Cancer De Cuello Uterino

    Nov 1, 2015, 00:00

  • Probiotics Significantly Reduce Mortality In Preterm Newborns With Necrotising Enterocolitis- Results of Large Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Avaliação da Adesão Ao Protocolo de Tratamento de Pessoas Vivendo Com Hiv/Aids- Conhecer Bem Para Cuidar Melhor

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento Del Cáncer De Mama En Una Aseguradora Colombiana

    Nov 1, 2015, 00:00

  • Acceptance of Clinically Relevant Primary Study Endpoints In The German Health Technology Assessment Process- Analysis of Five Different Disease Areas

    Nov 1, 2015, 00:00

  • Condiçoes Socioeconomicoculturais Das Famílias de Indivíduos Nascidos Com Fissura Labiopalatina

    Nov 1, 2015, 00:00

  • An Analysis of Medicine Procurement for Alzheimer’s Disease in Brazil From Federal Purchases

    Nov 1, 2015, 00:00

  • Disinvestment Initiatives in Latin American Countries (Lac)- a Systematic Literature Review (Slr)

    Nov 1, 2015, 00:00

  • Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making- A Nominal Group Technique And Best-Worst Scaling

    Nov 1, 2015, 00:00

  • Prevalência da Espondilite Anquilosante- Uma Revisão Sistemática

    Nov 1, 2015, 00:00

  • Persistence of Remission Among Patients With Inflammatory Bowel Disease After Adalimumab Therapy Is Stopped- Economic Implications

    Nov 1, 2015, 00:00

  • Challenges for Assessing The Economic Value of Orphan Drugs - A Literature Review of Current And Alternative Approaches

    Nov 1, 2015, 00:00

  • Systematic Review Of Economic Evaluations In Personalized Medicine

    Nov 1, 2015, 00:00

  • Turkish Reimbursement System For Medical Devices

    Nov 1, 2015, 00:00

  • Manufacturers’ Reactions in Response to the New Requirement for Cost-Effectiveness in France

    Nov 1, 2015, 00:00

  • Patient Count Forecasts of Advanced Non-Small Cell Lung Cancer- Results from the UK, Germany, France, Italy and Spain (Eu-5)

    Nov 1, 2015, 00:00

  • A Comparison of Classification and Regression Trees and Logistic Regression for Predicting Death of Older Long-Term Care Users in Japan

    Nov 1, 2015, 00:00

  • Can Patients Rely on Results of Physician Rating Websites When Selecting A Physician? - A Cross-Sectional Study Assessing The Association Between Online Ratings and Structural and Quality of Care Measures from Two German Physician Rating We ...

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »